Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new publication citation for the post hoc analysis of abrocitinib in atopic dermatitis was added to the Publications section, and the previous online-ahead-of-print citation was removed, reflecting a newer version of the paper.SummaryDifference0.0%

- Check19 days agoChange DetectedAn addition appears in the study identifiers: '2019 ( U.S. NIH Grant/Contract )', indicating NIH funding for the U.S. portion of the trial.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedA new post hoc analysis publication is added to the Publications section, and the previously listed publication entry is removed/updated to reflect its publication status.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page now lists Revision: v3.6.4, replacing the previous v3.6.3. This appears to be a minor revision tag update with no substantive changes to the study content in the provided data.SummaryDifference0.0%

- Check69 days agoChange DetectedA new PubMed publication citation by Weidinger et al. was added to the Publications section for the study. The page version was updated from v3.6.2 to v3.6.3.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page's revision tag advanced from v3.6.0 to v3.6.2, signaling a minor update to the page's documentation. The change does not modify trial content or functionality.SummaryDifference0.0%

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.